Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Akebia Therapeutics
Pharma
Akebia unveils IRA-driven high price for Vafseo
Despite uncertainties around a nondialysis expansion with the FDA, the company has decided to incorporate that indication in Vafseo's price now.
Angus Liu
Jul 11, 2024 10:54am
Akebia's Vafseo wins FDA approval 2 years after rejection
Mar 28, 2024 9:25am
After high-profile snub, Akebia plots vadadustat resubmission
Aug 24, 2023 10:40am
GSK scraps plan to launch oral anemia drug beyond US, Japan
Jul 26, 2023 10:21am
Akebia proposes new dosing for oral anemia drug amid FDA dispute
Apr 3, 2023 11:34am
After FDA snub, Akebia's oral anemia drug Vafseo nears EU nod
Feb 27, 2023 4:45pm
